SUSumarno

Sumarno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sumarno has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploratory immunoinformatic and single-donor ex vivo evaluation of methicillin-resistant Staphylococcus aureus virulence-factor peptide combinations in burn-associated bacteraemia: Implications for MRSA vaccine development

    by Arviansyah, Sumarno, Edi Mustamsir, Irene Ratridewi, Wisnu Barlianto, Dewi Santosaningsih

    This exploratory two-stage study combined immunoinformatic screening with ex vivo peripheral blood mononuclear cell (PBMC) stimulation from one 38-year-old man with a mid-deep dermal burn injury involving 35% total body surface area (TBSA) and confirmed methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Upstream candidate selection incorporated S. aureus /MRSA sequence matching and conservation screening against a nonredundant S. aureus pangenome comprising 1,038 GenBank genomes, together with antigenicity, predicted safety, and structural accessibility. Four predicted non-toxic, non-allergenic peptides (A1, A2, B, and H) were tested alone and in combinations for 72 h at 5 µg/mL per peptide using five technical replicate wells per condition. One-way ANOVA with Duncan post hoc testing showed that A2-B-H produced the broadest response profile, including higher CD33+CD38+ (+73%, p < 0.01), CD20+ (+42%, p < 0.01), and IL-4 (+37%, p < 0.01). A1-H yielded the highest CD3+CD16+ (+43%, p < 0.05) and TNF-α (+65%, p < 0.05), whereas A2-H produced the highest total IgG (+31%, p < 0.05). The integrated immunological score ranked A2-B-H highest (16.3/20). These findings support A2-B-H as the leading combination for subsequent functional and translational validation.

  • Open Access

    Induction of an 11 KDA Protein Epitope For Reducing Mrsa Bacterial Colony Counts Via Cellular and Humoral Adaptive Immune Responses In Postpartum MUS Musculus Infected With MRSA: A Strategy for Enhancing Public Health and Combating Antibiotic Resistance

    by Uswatun Hasanah, Sri Poeranto, Tatit Nurseta, I Wayan A. Wiyasa, Umi Kalsum, Muhammad Anas, Sumarno R. Prawiro, Edy Mustofa

    Objective: This study investigates how the 11 kDa protein epitope, from the cross-reaction between MRSA bacteria and L. reuteri, reduces MRSA colonies through adaptive immune responses (Th17, Th2), cytokines (IL-4, IL-22), and innate immunity (IgG antibodies) in postpartum Mus musculus. Method: A true experimental design was applied using Balb/c mice divided into seven groups, including controls and those treated with different combinations of L. reuteri, MRSA proteins, and peptides. Cellular immunity (Th17, Th2), cytokines (IL-4, IL-22), IgG antibodies, and MRSA colonies were measured post-treatment. Results & Discussion: The candidate vaccine enhanced cellular adaptive immunity (Th2, Th17), cytokine responses (IL-4, IL-22), and reduced MRSA colonies. IgG levels were notably higher in Groups K3 and K6 compared to K1. Conclusion: The 11 kDa protein epitope, from the MRSA-L. reuteri cross-reaction, effectively modulates adaptive immunity, reducing MRSA colonies in postpartum Mus musculus.

  • Open Access

    Effect of casein supplementation on HBD-1, Th-17 and IL22 in a preterm Rattus norvegicus chorioamnionitis model

    by Hari Paraton, Aulanni'Am Aulanni'Am, I. Wayan Arsana Wiyasa, Alifah Wahyu Harian, Widjiati, Sumarno Reto Prawiro

    Purpose: To investigate casein's role in the expressions of human beta-defensin (HBD)-1, T helper subset (Th)-17, and interleukin (IL)-22 in preterm Rattus norvegicus (RNs). Methods: Twenty-four healthy, first-time pregnant RNs were divided into three groups (G). Group 1 (G1) received regular casein (R) 0.4 g/RN/day, while G2 and G3 received casein supplementation (S) 2 g/RN/ day. Each RN was given 10 g of food and drank 10 mL. On day 10, a single intraperitoneal lipopolysaccharide (LPS) was injected with 100 g/kg body weight. Lipopolysaccharide was injected into G3 as a premature model with chorioamnionitis. Histopathological examination was carried out to measure the expression of HBD-1, Th-17, and IL-22 using methyl green counterstaining. Chorioamnion specimens were taken and fixed in 4 % paraformaldehyde, and then evaluated by immunohistochemical (IHC) procedures to obtain immunoreactive score (IMS). Results: The IMS expression of HBD-1 in G1 was 1.187 ± 0.372, while G3 was 9.562 ± 2.351 (p < 0.05). Th-17 expression were G1: 2.062 ± 0.140, G2: 6.122 ± 1.347, and G3: 9.112 ± 2.019 (p < 0.05). Furthermore, IL-22 expressions were G1: 1.825 ± 0.468, G2: 4.700 ± 1.614, and G3: 7.800 ± 1.669 (p < 0.05). Conclusion: Casein supplementation increases HBD-1, Th-17, and IL-22 expression in preterm RN and in the LPS- induced RN chorioamnionitis model. The increase in HBD-1, Th-17, and IL-22 indicate that casein plays a role in the protection and control of chorioamnionitis tissue inflammation.

  • Open Access

    Cross Protectivity Analysis of 49.8 kDa Pili Subunits of S. flexneri against Vibrio cholerae Infection

    by Dwi Yuni Nur Hidayati, Septha Rully, Aisyah Amalia, Elsa Larissa Widyani, Genitri Indraswari, Adrian Prasetya, Merika Soraya, Sri Winarsih, Sumarno Reto Prawiro

    Background. Although the AMV and AMS vaccine candidates have similar characteristics as hemagglutinin and adhesive molecules, there are differences in molecular weight. Objective. The research aims to determine the immunological cross-reaction between AMS and AMV. Method. Antihemagglutination test used the anti-adhesion molecular antibody AMS. Next, we examined the immune response that has to be linked with protectivity. The model of the research uses MLIL. The sample separated the mice into four groups, and each group had five mice. The first group was the negative control group. The second group was given AMV and infected with Shigella flexneri. The third group was immunized with AMV before being exposed to Shigella flexneri. The last group was infected with Vibrio cholerae. The immune response results were evaluated by calculating the weight of MLIL and counting the colony of bacteria. We also examined other AMS immune responses, namely, β-defensin and s-IgA levels. To get the data, we measured the number of Th17 immune effector cells, T-reg, and proinflammatory cytokine IL-17A. Data analysis was performed using ANOVA, independent t-test, Kruskal–Wallis, and Mann–Whitney tests. Results. An antihemagglutination cross immune response, intestinal weight, the number of bacterial colonies, and other findings were found to be significant ( ) for the levels of β-defensin, s-IgA, Th17, T-reg, and IL-17A. Conclusion. The 49.8 kDa·MW protein subunit of the Shigella flexneri adhesion molecule could act as a candidate vaccine homologous for shigellosis and cholera in the future.


  • Open Access

    IMMUNE RESPONSE ON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES AG-38 KDA MYCOBACTERIUM TUBERCULOSIS AND RIFAMPICIN EX-VIVO.

    by Tri Yudhani Mardining Raras, Almira Fahrinda, Yuliati Yuliati, Dwi Yuni Nurhidayati, Hidayat Sujuti, Sumarno Reto Prawiro

    Background: Development a granuloma model resembling latent tuberculosis in vitro is needed with a fast and efficient time to be used as an effective therapy. This study aimed to form efficient granulomas, increase cellular immunity and humoral immunity, and evaluate growth on media using recombinant protein antibody Ag38kDa, Rifampicin, and a combination of both. Peripheral Blood Mononuclear Cell (PBMC) in vitro is derived from a healthy individual separated from monocytes and lymphocytes. Materials and methods: Monocytes are matured into macrophages and then combined macrophages and lymphocytes to the Roswell Park Memorial Institute (RPMI) medium. Flow cytometry analysis was used to count the number of cells, and cytokine levels were measured using ELISA. The result from the treatment was planted on the Lowenstein-Jensen medium. Results: Granulomas-like aggregates was formed after one-day post-infection with Mycobacterium tuberculosis (M.tb). A significant increase in immune response occurred in the number of macrophages, Th1, and Tregs in the combination group compared to the Mtb infection group. The number of Th2 and Th17 cells in the combination group was compared with the control but not significantly. TNF-α cytokine levels increased in the combination group compared to Mtb infection, while in IL-4, we found between all groups, there was no significant difference. Bacterial colonies on culture in the Lowenstein-Jensen medium were only seen in positive controls. Conclusion: Our study concluded that administration of a combination between Ag38kDa recombinant antibody and rifampicin could inhibit granuloma formation and enhance immune response.


    • 1 September 2021
      • Vol. 15  (2 Suppl) , 23-30
    Open Access

    GENERATING RESPONSES IMMUNE IN CELLULAR AND HUMORAL TREATMENT WITH EPITOPE SPIKE, EPITOPE ENVELOPE PROTEIN, AND EPITOPE MEMBRANE PROTEIN SARS-COV-2, HONEY, SAUSSUREA LAPPA, AND NIGELLA SATIVA

    by Sumarno Reto Prawiro, Meike Tiya Kusuma, Reyhan Amiruddin, Irma Nur Sukmawati, Yuyun Kusnaningrum, Jayshri Davi S Nadarajah, Khoirul Anam, Tri Yudani Mardining Raras, Sri Winarsih

    Covid-19 has become pandemic in the World, including Indonesia. Our last study showed that HSF could serve as an immunomodulator. Using the exact search, we found that the most immuno-dominant SARS-COV2 epitope, namely A spike protein epitope, B envelope protein epitope, and C membrane protein epitope, we concise to be HF We used to post only control design study and mice as an animal model. The research divided mice into four groups, and the first group as control received PBS as a placebo. The second, three, and last four groups gave HF, HSN, and HFHSN (combine HF and HSN). All of the regiment enters the mouth with a special sonde to reach the gastrointestinal organ. We gave HF every week three times and HSN once a day. After administration regiments for a long three weeks, we sacrificed the mice. We evaluated cellular immune responses that are Th-2, Th-17, and NK cells. We check for humoral immune response, TGF-β,IL-17A, IL-4, IgG,IL-4, β-defensin, and s-IgA. Highest profile cellular immunity HF, HSN, and HFHSN were NK cell, Th-2 and Th-17, and the last NK cell, respectively. After that which in humoral immunity, the domination response IgG and IL-4 were HF. But HSN and HFHSN dominated for s-IgA and β-defensin production. By using the study Bio-Informatica, we found HF. If the results of this study are continued to the clinical trial level, it is necessary to recommend additional markers such as CTL (s-IgA and β-defensin in lung tissue)and CPE assay.

  • Open Access

    Antigen of 49.6-kDa subunit pili protein of Helicobacter pylori as a potential biomarker for early and rapid detection of the infection

    by Hamong Suharsono, Zainul Muttaqin, I Wayan Masa Tenaya, Kadek Karang Agustina, Sumarno Retro Prawiro

    Background and Aim: Helicobacter pylori infection has been identified as a major cause of peptic ulcer diseases, including gastric and duodenal ulcers, gastritis, chronic and gastric carcinoma, and even gastric lymphoma. In vitro studies using Western blotting analysis, hemagglutination test, adherence inhibition assays, and immunocytochemical staining revealed that the 49.6-kDa subunit pili protein of H. pylori was considered an immunogenic protein. This study aimed to develop a serological diagnostic test using 49.6 kDa for detecting antibodies against H. pylori proteins in an early phase of the infection. Materials and Methods: An in-house immunochromatographic test (ICT) kit was developed and used to test a panel of sera sample obtained from a randomly selected symptomatic patient, in which 40 sera were H. pylori positive and 40 sera were H. pylori negative. Results: The results showed that ICT with 49.6 kDa as an antigen was highly sensitive and specific for detecting anti-H. pylori immunoglobulin G antibodies in human serum, with a high negative predictive value. Conclusion: The developed test could be used to exclude H. pylori infection in symptomatic patients.


  • Open Access

    Antibodies against Shigella flexneri adhesion molecule outer membrane protein (OMP) can cross-react with OMPs of some Shigella species

    by Alvi Milliana, A.S. Noorhamdani, Sri Poeranto, Kusworini Handono, Sumarno Reto Prawiro, Avin Ainur Fitrianingsih, Lailia Nur Rachma

    Purpose: To identify a Shigella flexneri hemagglutinin outer membrane protein (OMP) as an adhesion factor and examine its ability to cross-react with the OMPs of other Shigella species. Methods: OMP was isolated from the bacterium S. flexneri after shaving the pili using a pili bacterial cutter in a solution of 0.5 % n-octyl-β-D-glucopyranoside. Hemagglutination was evaluated using mice erythrocytes. The molecular weight (MW) of the OMPs was profiled by SDS-PAGE. Adhesion molecules were identified by calculating the index of adhesion. Thereafter, antigen cross-reaction with antibodies was examined by Western blotting, Results: The S. flexneri adhesion molecule OMP has a MW of 28 kDa. An antibody against the 28 kDa S. flexneri OMP adhesion molecule cross-reacted with different MW OMPs from other Shigella species. Conclusion: This study showed that the 28 kDa S. flexneri OMP is a hemagglutinin adhesion protein, and antibodies against it can cross-react with the OMPs of other Shigella species. Keywords: Shigella flexneri OMP, Outer membrane protein, Protein adhesion, Antibody, Cross-reaction